Home Icon
Ha Noi CPC1 Pharmaceutical JSCLeading Pharmaceutical Technology
(+84) 98 440 46 50
English

Topi Nebuliser

Ảnh sản phẩm

Active Element: Tobramycin 300mg/5ml

Dosage Form:

Composition

Tobramycin 300mg/5ml

Dosage Form

Solution for Nebuliser

Indication

Topi Nebuliser is indicated for the treatment of chronic lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis 6 years of age and older.

Off label:

- Severe chronic obstructive pulmonary disease (COPD) with Pseudomonas aeruginosa infection

- Hospital-acquired pneumonia or ventilator-associated pneumonia (VAP) (especially caused by Pseudomonas aeruginosa), especially when other routes of administration are not feasible or effective.

- Bronchiectasis in non-cystic fibrosis patients

- Chronic respiratory tract infections developing during the course of Wegener's granulomatosis

- Acute bacterial rhinopharyngitis in children

- Chronic sinusitis, chronic nasal polyps in cystic fibrosis patients

Related Products

Ha Noi CPC1 Pharmaceutical JSC
Contact Us
Ha Noi CPC1 Pharmaceutical JSCHa Binh Phuong Industrial Zone, Thuong Tin District, Hanoi, VietnamWhatsApp/Viber/Mobile: (+84) 98 440 46 50
FacebookLinkedinTrustPass
Copyright © CPC1HN 2024